World Cancer Day 2025: United by Unique

We are commemorating World Cancer Day by sharing a selection of Springer Nature journal articles, collections, clinical trial registrations and blog posts chosen by our publishers.
World Cancer Day 2025: United by Unique
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

World Cancer Day is observed every 4th February to raise awareness of cancer and mobilise action to address the global cancer epidemic. Since it was established by the Union for International Cancer Control (UICC) in the year 2000, World Cancer Day has aimed to catalyse personal, collective and government action to make life-saving cancer treatment and care available to all. World Cancer Day campaigns run in three-year cycles and the theme for 2025-2027 is “United by Unique”, which places people at the centre of care and reflects the fact that every experience with cancer is unique.

This blog post for World Cancer Day highlights recent Springer Nature journal articles, collections, clinical trial registrations and blog posts chosen by our publishers. All are related to the Sustainable Development Goals, specifically SDG 3: "Ensure healthy lives and promote well-being for all at all ages", and the related key target 3.4: “By 2030, reduce by one third premature mortality from non-communicable diseases.

Highlights from Springer Nature journals

In collaboration with Dr Liu (Editor-in-Chief of Biological Procedures Online), Dr Kioumarsi (Editorial Board Member of Hereditas and Biological Procedures Online) co-authored an editorial reflecting on World Cancer Day and its connection to the Sustainable Development Goals. A Q&A prepared by India Sapsed-Foster and Dr Kioumarsi accompanies the editorial on Research Communities.

The editor-in-chief and editorial board members of Biology Direct have collaborated on an editorial where they share that World Cancer Day is not just a day of reflection but also a call to action to accelerate innovation, foster global collaboration, and ensure that every patient can benefit from the promise of personalized medicine.

Scientific Reports has published a proof-of-concept study of non-invasive screening of breast cancer from fingertip smears, as well as the results of deep learning and machine learning approaches for the prediction of cancer drug synergy. These have the potential to identify novel therapeutic combinations to reduce resistance to traditional therapeutic options.

Other recent AI research includes a study assessing ChatGPT’s capabilities in providing therapeutic recommendations for head and neck cancers, unsupervised machine learning for categorising distinct phenotypes among pediatric patients undergoing chemotherapy, and a deep-learning method to discriminate cancer types from standard histology images.

A study in Human Genetics has shown that known risk loci for endometrial cancer explain approximately one third of familial endometrial cancer, while another study has found a pan-cancer gene signature to identify patients who could benefit from copper-chelation therapy.

An article in Breast Cancer Research shows that clinically relevant gene signatures provide independent prognostic information in older breast cancer patients.

A population study in the World Journal of Surgical Oncology of cancer risk in kidney transplant patients has found a possible link between immunosuppression and cancer, especially for tumors linked to viral infections.

Studies published in the Journal of the Egyptian National Cancer Institute have found that metabolic syndrome and its components are associated with breast cancer risk, and that intermittent fasting during chemotherapy in breast cancer patients may decrease its toxicity and increase its clinical efficacy.

Results published in Radiation and Environmental Biophysics confirm that residential radon exposure is an important risk factor for lung cancer, highlighting the need for protective measures against radon.

A cohort study in BMC Medicine has found that making multiple, combined healthier lifestyle changes during adulthood was associated with lower cancer mortality and delayed risk of death.

Molecular Cancer has published a comprehensive review of the CRISPR-based gene editing strategies that have been proposed for cancer therapy, including inactivating genes that drive tumor growth, enhancing the immune response to cancer cells, repairing genetic mutations that cause cancer, and delivering cancer-killing molecules directly to tumor cells. There is also a review of the clinical efficacy of FDA-approved antibody‒drug conjugates in human cancers.

A perspective piece in BMC Global and Public Health looked at the challenges in understanding inequities in help-seeking for possible cancer symptoms, while a protocol in Implementation Science Communications describes a trial of personalized reminders for surveillance tests in adult survivors of childhood cancer.

The British Dental Journal has published a review of the current literature on the effects of e-cigarettes/vapes on oral cancer risk and research into whether the COVID-19 pandemic had an effect on oral cancer diagnosis rates. There are also helpful guides for dentists on spotting skin cancer and on the dental management of patients who have had or will undergo radiotherapy.

United by Unique

Collections calling for submissions

Scientific Reports is inviting researchers to submit their manuscripts for collections on inflammation and metastasis, triple-negative breast cancer and pediatric cancers.

BMC Biology has open calls for papers on stem cells and cancer, ferroptosis, aging microenvironment and disease and immunosenescence.

In other journals there are also open calls for content on the interruption of amino acids supply as an anti-tumor strategy, the oncobiome, Phase I clinical trials, and the implementation of cancer strategies in primary care.

ISRCTN clinical study registry

Among the many cancer clinical trials registered at the ISRCTN registry in 2024, highlights include the NHS Cancer Vaccine Launch Pad, an observational cohort study which aims to speed up the development of personalised cancer vaccines. The ExPeL study is looking at whether a device that detects hydrogen peroxide in exhaled breath can be used for early detection of lung cancer. The KETO-Lung study aims to find out whether following a ketogenic diet enables chemotherapy and immunotherapy to work more effectively in patients with lung cancer.

Springer Nature Research Communities

To find insightful blog posts related to World Cancer Day, you can explore the Springer Nature Research Communities website, particularly the Cancer Community. This platform hosts a variety of articles and discussions from experts in the field, with recent posts discussing the expression of cuproplasia-related genes in cancer patients and the PICCOS trial of experimental spray chemotherapy. You can also watch a recent seminar from the SN Oncology Webinar Series on the public engagement project Radiation Reveal. Use the search function on the website to discover relevant content and stay informed about the latest developments and initiatives.

Conclusion

If you want to get involved in World Cancer Day this year you can visit the UICC’s official website, read their how to guides on how to be an advocate, fundraise, organise an event and reach out to the media, and also access their social media resources.

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Cancer Screening
Life Sciences > Biological Sciences > Cancer Biology > Cancer Screening
Cancer Therapy
Life Sciences > Biological Sciences > Cancer Biology > Cancer Therapy
Cancer Genetics and Genomics
Life Sciences > Biological Sciences > Genetics and Genomics > Cancer Genetics and Genomics
Cancer Imaging
Life Sciences > Biological Sciences > Cancer Biology > Cancer Imaging
Randomized Controlled Clinical Trials
Life Sciences > Health Sciences > Biomedical Research > Clinical Research > Clinical Trials > Clinical Trial Design > Randomized Controlled Clinical Trials
Clinical Research
Life Sciences > Health Sciences > Biomedical Research > Clinical Research

Related Collections

With collections, you can get published faster and increase your visibility.

Autoimmune disorders

BMC Medicine is calling for submissions to our Collection on autoimmune disorders.

Autoimmune disorders encompass a diverse group of conditions in which the immune system mistakenly attacks the body's own cells, leading to chronic inflammation and tissue damage. These disorders can affect multiple organs and systems including the dermatological, digestive, endocrine, neuro-muscular, rheumatic, and vascular. The complexity of autoimmune disorders lies in their heterogeneity, with over 100 recognized autoimmune diseases, each with its unique pathogenesis and clinical manifestations. Understanding the underlying mechanisms of inflammation and autoimmune disorders is crucial for developing effective diagnostic tools and targeted therapies.

By advancing our collective understanding of autoimmune disorders, we hope to discover new therapeutic targets, develop precision medicine strategies tailored to individual autoimmune conditions, and explore innovative immunomodulatory interventions.

Topics of interest for this Collection include, but are not limited to:

Mechanisms of antibody and immune dysregulation

Inflammatory mechanisms underlying specific autoimmune diseases

Genetic and environmental factors influencing autoimmune disease susceptibility

Novel diagnostic/prognostic biomarkers for autoimmune disorders

Neuroinflammation and autoinflammatory disorders

Autoimmune diseases affecting specific systems (e.g., rheumatoid arthritis, celiac disease, multiple sclerosis, type 1 diabetes)

Diagnosis and classification criteria for autoimmune disorders

Advances in drug discovery and clinical trials testing therapeutic interventions

Autoimmunity and cancer: intersections and implications

Impact of autoimmune disorders on quality of life and psychosocial well-being (patient and public involvement (PPI) containing lived experiences will be considered)

Emerging technologies and methodologies in autoimmune research

Effects of COVID-19 and infections on autoimmunity

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.

This Collection supports and amplifies research related to SDG 3: Good Health and Well-being

Publishing Model: Open Access

Deadline: Jun 28, 2025

Biomarkers for Early Detection of Cardiotoxicity

Cardio-Oncology is calling for submissions to our Collection on 'Biomarkers for Early Detection of Cardiotoxicity.' This Collection seeks to highlight cutting-edge research on the identification and validation of biomarkers that can predict cardiotoxicity at an early stage.

Publishing Model: Open Access

Deadline: Sep 30, 2025